RxDoctor Payments Data

Michael Eckstrom

Psychiatric/Mental Health · Council Bluffs, IANPI 1093416729

Payments from drug & device makers

$524in general payments, 2019–2025

Across 18 payments — averaging $29.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$216
  • Supernus Pharmaceuticals, Inc.$146
  • Otsuka America Pharmaceutical, Inc.$37
  • Johnson & Johnson$33
  • Alkermes, Inc.$29
  • Axsome Therapeutics, Inc.$27
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$524100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$524 in reported general payments places this provider in the 40th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$16,760
Medicare patients
41
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole11$23,130
Aripiprazole46$6,910
Quetiapine Fumarate51$2,154
Olanzapine85$1,634
Divalproex Sodium16$952
Trazodone Hcl120$901
Lurasidone Hcl15$881
Venlafaxine Hcl ErVenlafaxine Hcl31$548
Fluvoxamine Maleate12$536
Risperidone51$524
Prazosin Hcl31$520
Topiramate50$484
Oxcarbazepine20$461
Gabapentin53$432
Hydroxyzine Hcl24$406

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$37$23,13011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Council Bluffs

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →